Alzheimer's disease in Down syndrome: Neurobiology and risk

Wiley - Tập 13 Số 3 - Trang 237-246 - 2007
Warren B. Zigman1,2, Ira T. Lott2
1Department of Psychology, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, New York
2Departments of Pediatrics and Neurobiology, University of California, Irvine, University of California Medical Center, Orange, California

Tóm tắt

AbstractDown syndrome (DS) is characterized by increased mortality rates, both during early and later stages of life, and age‐specific mortality risk remains higher in adults with DS compared with the overall population of people with mental retardation and with typically developing populations. Causes of increased mortality rates early in life are primarily due to the increased incidence of congenital heart disease and leukemia, while causes of higher mortality rates later in life may be due to a number of factors, two of which are an increased risk for Alzheimer's disease (AD) and an apparent tendency toward premature aging. In this article, we describe the increase in lifespan for people with DS that has occurred over the past 100 years, as well as advances in the understanding of the occurrence of AD in adults with DS. Aspects of the neurobiology of AD, including the role of amyloid, oxidative stress, Cu/ZN dismutase (SOD‐1), as well as advances in neuroimaging are presented. The function of risk factors in the observed heterogeneity in the expression of AD dementia in adults with DS, as well as the need for sensitive and specific biomarkers of the clinical and pathological progressing of AD in adults with DS is considered. © 2007 Wiley‐Liss, Inc. MRDD Research Reviews 2007;13:237–246.

Từ khóa


Tài liệu tham khảo

10.1212/WNL.53.9.1992

10.1212/01.WNL.0000137040.64252.ED

10.1006/exnr.2000.7359

10.1002/jcp.1041050319

10.1073/pnas.93.16.8530

10.1001/archpsyc.62.6.685

10.1093/eurpub/ckl103

10.1093/gerona/57.7.M470

10.1016/S1474-4422(03)00530-1

10.1016/0165-3806(84)90060-9

10.1111/j.1471-4159.1985.tb12896.x

10.1111/j.1749-6632.1998.tb09021.x

10.1038/378776a0

10.1352/0895-8017(2004)109<83:RFFDIP>2.0.CO;2

10.1016/S0024-3205(02)01538-2

10.1016/S0002-9440(10)64538-5

10.1111/j.1532-5415.1982.tb05065.x

10.1126/science.8346443

10.1046/j.1365-2788.1999.00192.x

10.1006/abbi.1997.0109

10.1016/0278-5846(86)90010-2

10.1097/00001756-199611250-00026

10.1590/S0100-879X2000000500007

de Haan JB, 1995, Cu/Zn‐superoxide dismutase and glutathione peroxidase during aging, Biochem Mol Biol Int, 35, 1281

10.1192/bjp.176.5.468

10.1016/S0022-510X(96)00249-3

10.1016/0304-3940(88)90597-6

Devenny DA, 1996, Normal ageing in adults with Down's syndrome: A longitudinal study, J Intellect Disabil Res, 40, 208, 10.1111/j.1365-2788.1996.tb00624.x

Down JLH, 1866, Observations on an ethnic classification of idiots, London Hospital Reports, 3, 259

10.1159/000052801

10.1001/archneur.59.10.1589

10.1002/j.1460-2075.1986.tb04255.x

10.1096/fj.03-0451com

10.1212/WNL.54.1.240

10.1001/archneur.1991.00530180051017

10.1002/ajmg.1320370760

Fraser J, 1876, Kalmuc idiocy: report of a case with autopsy with notes on sixty‐two cases, J Ment Sci, 22, 169, 10.1192/bjp.22.98.169

Furuta A, 1995, Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus, Am J Pathol, 146, 357

Gage FH, 1986, Compensatory collateral sprouting of aminergic systems in the hippocampal formation following partial deafferation, Hippocampus, 3, 33

10.1126/science.4071042

10.1002/ajmg.1320370754

10.1034/j.1399-0004.2002.620506.x

10.1002/ajhb.10132

Goldgaber D, 1987, Isolation, characterization, and chromosomal localization of human brain cDNA clones coding for the precursor of the amyloid of brain in Alzheimer's disease. Down's syndrome and aging, J Neural Transm Suppl, 24, 23

10.1056/NEJM199609123351106

10.1016/S0304-3940(02)01150-3

Green RC, 2002, Statin use is associated with reduced risk of Alzheimer's disease, Neurobiol Aging, 23, S273

10.1212/01.WNL.0000098935.36984.25

10.1016/j.neuroimage.2004.11.019

10.1001/jama.297.11.1224

10.1093/jnen/62.9.917

10.3233/JAD-2007-11110

10.1093/aje/153.2.132

10.1016/j.neuroscience.2005.06.017

10.1007/s00406-005-0596-4

10.1002/ana.410140503

10.1192/bjp.172.6.493

10.1046/j.1365-2788.2000.00263.x

10.1016/S0197-4580(01)00252-4

10.1016/S0197-4580(03)00046-0

10.1001/archneur.1995.00540280059019

10.1177/153331750101600207

10.1352/0047-6765(2000)038<0276:PODAIO>2.0.CO;2

10.1016/j.neurobiolaging.2005.05.021

10.1176/ajp.105.2.102

10.1016/S0140-6736(00)03155-X

Johannsen P, 1996, The prevalence of dementia in Down syndrome, Dementia, 7, 221

Jorm A, 1996, The First Shizuoka Forum on Health and Longevity

10.1002/ana.410250402

Khoury MJ, 1993, Fundamentals of genetic epidemiology, 383

10.1136/bmj.322.7300.1447

Korenberg JR, 1990, Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype, Am J Hum Genet, 47, 236

10.1196/annals.1297.065

10.1212/WNL.53.2.331

10.1001/archneur.1989.00520440031017

10.1016/S0140-6736(00)04063-0

Landesman‐Dwyer S, 1981, Living in the community, Am J Ment Defic, 86, 223

10.1212/WNL.57.8.1447

Lejeune J, 1959, Study of somatic chromosomes from 9 mongoloid children, CR Hebd Seances Acad Sci, 248, 1721

Lejeune J, 1959, A study of somatic chromosomes in nine infants with mongolism, CR Acad Sci (Paris), 240, 1026

10.1146/annurev.pharmtox.41.1.347

10.1006/exnr.1997.6777

10.1016/S0891-5849(03)00358-7

10.1016/j.neurobiolaging.2004.08.005

10.2174/156720506779025305

10.1016/0968-0004(92)90404-W

10.1111/j.1365-2230.2006.02164.x

10.1007/978-1-4684-8503-5_6

10.1177/0891988705281868

10.1111/j.1365-2990.1986.tb00053.x

Masaki M, 1981, Mortality and survival for Down syndrome in Japan, Am J Hum Genet, 33, 629

Mausner JS, 1985, Mausner and Bahn epidemiology: an introductory text

10.1212/01.WNL.0000091890.32140.8F

10.1002/ana.410340527

Miniño A, 2006, Deaths: preliminary data for 2004

2006 Morbidity and Mortality Weekly Report CD Control Improved national prevalence estimates for 18 selected major birth defects—United States 1999–2001 1301 1305

10.1001/jama.283.12.1571

10.1046/j.1365-2788.2001.00379.x

Newberger DS, 2000, Down syndrome: prenatal risk assessment and diagnosis, Am Fam Physician, 62, 825

10.1016/j.neurobiolaging.2006.06.023

10.1016/0921-8734(90)90015-J

10.1007/s004010050959

10.1017/S0033291798007417

10.1046/j.1471-4159.1994.62031062.x

10.1016/S0197-4580(02)00043-X

10.1016/S0197-4580(03)00089-7

Penrose LS, 1949, The incidence of Mongolism in the general population, J Ment Sci, 95, 685, 10.1192/bjp.95.400.685

10.1176/ajp.154.8.1063

10.1056/NEJM199511093331902

10.1352/0895-8017(1997)102<0103:AGAADI>2.0.CO;2

Prasher VP, 1996, Causes of age‐related decline in adaptive behavior of adults with Down syndrome: differential diagnoses of dementia, Am J Ment Retard, 101, 175

10.1002/ana.410430316

10.1042/bst021221s

10.1016/j.neurobiolaging.2004.06.019

10.1016/S0140-6736(87)91754-5

Rocca WA, 1987, The etiology of Alzheimer's disease: epidemiologic contributions with emphasis on the genetic hypothesis, J Neural Transm Suppl, 24, 3

10.1212/01.wnl.0000251303.50459.8a

Roizen NJ, 1997, Children with disabilities, 361

10.1212/WNL.53.3.517

10.1038/ng1718

10.1097/00001756-199412000-00044

10.1002/(SICI)1096-8628(19990820)88:4<344::AID-AJMG10>3.0.CO;2-1

10.1212/WNL.43.8.1467

10.1212/WNL.38.6.938

10.1038/jcbfm.1990.35

10.1016/S0733-8619(18)30981-2

10.1192/bjp.180.5.405

10.1016/S0140-6736(94)91398-6

10.1002/ana.410400518

10.1212/WNL.50.4.991

10.1002/ana.10677

10.1001/archneur.64.7.1007

10.1016/S0304-3940(01)01657-3

10.1016/j.neulet.2006.07.062

10.1046/j.1365-2788.1997.03838.x

10.1126/science.6224294

10.1111/j.1365-2788.2001.00286.x

10.1001/jama.291.24.2947

10.1352/0895-8017(2004)109<111:DIAWMR>2.0.CO;2

10.1097/00013614-199803000-00007

10.1038/382120b0

10.1001/jama.1996.03530310034029

10.1016/S0022-510X(98)00297-4

10.1097/01.wad.0000213815.20177.19

10.1007/BF02876635

10.1038/ncpneuro0448

10.1016/S0140-6736(96)03356-9

10.1126/science.2949367

10.1007/s10519-006-9047-x

10.1016/S1474-4422(06)70501-4

10.1111/j.1365-2788.1996.tb00646.x

Victor M, 2001, Adams and Victor's principles of neurology, 1692

10.1038/416535a

10.1111/j.1432-1033.1993.tb19864.x

10.1159/000017217

10.1212/WNL.55.10.1455

10.1111/j.1749-6632.1986.tb40344.x

10.1002/ana.410170310

10.1073/pnas.85.16.6202

10.1016/S0140-6736(00)02628-3

10.1016/S0140-6736(02)08092-3

10.1016/0022-510X(87)90238-3

10.1093/ageing/afj030

ZigmanW JenkinsE MehtaP et al.2000. Alzheimer's disease survival and genetics in the “oldest old” with Down syndrome. Down syndrome research foundation (Canada)/National Down Syndrome Society (US) new directions in down syndrome research conference Toronto Canada.

10.1016/j.neulet.2005.08.002

10.1111/j.1365-2788.1997.tb00679.x

10.1016/j.neulet.2007.02.023

Zigman WB, 1996, Prevalence of dementia in adults with and without Down syndrome, Am J Ment Retard, 100, 403

ZigmanW SchupfN SilvermanW.2005b. Cognitive reserve and dementia risk in adults with Down syndrome. 38th Annual Gatlinburg Conference on Research and Theory in Intellectual and Developmental Disabilities Annapolis MD.

10.1352/0895-8017(2002)107<0161:IATPOA>2.0.CO;2

10.1016/S0074-7750(08)60188-3

10.1002/(SICI)1098-2779(1996)2:2<73::AID-MRDD3>3.0.CO;2-Y